Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 3054-3063

  Eaton, Kathryn A ^a,b,d   Friedman, David I ^b   Francis, Gayle J ^a   Tyler, Jessica S ^b,e   Young, Vincent B ^b   Haeger, Jennifer ^a   Abu Ali, Galeb ^c   Whittam, Thomas S ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d 018 Animal Research Facility   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CECUM; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DEHYDRATION; DELETION MUTANT; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ERYTHROCYTE; FECES; FEMALE; INOCULATION; INTESTINE EPITHELIUM; KIDNEY DISEASE; KIDNEY TUBULE NECROSIS; LETHARGY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; THROMBOSIS; ANIMAL; BACTERIAL COUNT; CLASSIFICATION; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; GENETICS; GERMFREE ANIMAL; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; INTESTINE; KIDNEY FAILURE; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY; PATHOPHYSIOLOGY; VIRULENCE;

ANIMALS; COLONY COUNT, MICROBIAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FEMALE; GERM-FREE LIFE; INTESTINES; KIDNEY DISEASES; KIDNEY FAILURE; MALE; MICE; MUTATION; SEVERITY OF ILLNESS INDEX; SHIGA TOXIN 2; VIRULENCE;

EID: 46449121636     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01626-07     Document Type: Article

References (54)

1. Aiba, Y., H. Ishikawa, K. Shimizu, S. Noda, Y. Kitada, M. Sasaki, and Y. Koga. 2002. Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine model. Microbiol. Immunol. 46:723-731.
2. Amirlak, I., and B. Amirlak. 2006. Haemolytic uraemic syndrome: an overview. Nephrology 11:213-218.
3. Asahara, T., K. Shimizu, K. Nomoto, T. Hamabata, A. Ozawa, and Y. Takeda. 2004. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 72:2240-2247.
4. Bibiloni, R., M. A. Simon, C. Albright, B. Sartor, and G. W. Tannock. 2005. Analysis of the large bowel microbiota of colitic mice using PCR/DGGE. Lett. Appl. Microbiol. 41:45-51.
5. Centers for Disease Control and Prevention. 2006. Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach - United States, September 2006. MMWR Morb. Mortal. Wkly. Rep. 55:1045-1046.
6. Cody, S. H., M. K. Glynn, J. A. Farrar, K. L. Cairns, P. M. Griffin, J. Kobayashi, M. Fyfe, R. Hoffman, A. S. King, J. H. Lewis, B. Swaminathan, R. G. Bryant, and D. J. Vugia. 1999. An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann. Intern. Med. 130:202-209.
7. Conlan, J. W., and M. B. Perry. 1998. Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can. J. Microbiol. 44:800-805.
8. Court, D. L., J. A. Sawitzke, and L. C. Thomason. 2002. Genetic engineering using homologous recombination. Annu. Rev. Genet. 36:361-388.
9. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645.
10. Donohue-Rolfe, A., I. Kondova, S. Oswald, D. Hutto, and S. Tzipori. 2000. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J. Infect. Dis. 181:1825-1829.
11. Fernandez, G. C., M. F. Lopez, S. A. Gomez, M. V. Ramos, L. V. Bentancor, R. J. Fernandez-Brando, V. I. Landoni, G. I. Dran, R. Meiss, M. A. Isturiz, and M. S. Palermo. 2006. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin. Exp. Immunol. 146:76-84.
12. Fujii, J., T. Kita, S. Yoshida, T. Takeda, H. Kobayashi, N. Tanaka, K. Ohsato, and Y. Mizuguchi. 1994. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect. Immun. 62:3447-3453.
13. Gomez, S. A., G. C. Fernandez, S. Vanzulli, G. Dran, C. Rubel, T. Berki, M. A. Isturiz, and M. S. Palermo. 2003. Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome. Clin. Exp. Immunol. 131:217-224.
14. Griffin, P. M., S. M. Ostroff, R. V. Tauxe, K. D. Greene, J. G. Wells, J. H. Lewis, and P. A. Blake. 1988. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann. Intern. Med. 109:705-712.
15. Ikeda, M., S. Ito, and M. Honda. 2004. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr. Nephrol. 19:485-489.
16. Isogai, E., H. Isogai, K. Kimura, S. Hayashi, T. Kubota, N. Fujii, and K. Takeshi. 1998. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect. Immun. 66:197-202.
17. Jeon, B., and K. Itoh. 2007. Production of Shiga toxin by a luxS mutant of Escherichia coli O157:H7 in vivo and in vitro. Microbiol. Immunol. 51:391-396.
18. Karch, H., P. I. Tarr, and M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int J. Med. Microbiol. 295:405-418.
19. Karpman, D., H. Connell, M. Svensson, F. Scheutz, P. Alm, and C. Svanborg. 1997. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J. Infect. Dis. 175:611-620.
20. Keepers, T. R., M. A. Psotka, L. K. Gross, and T. G. Obrig. 2006. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J. Am. Soc Nephrol. 17:3404-3414.
21. Kuehl, C. J., H. D. Wood, T. L. Marsh, T. M. Schmidt, and V. B. Young. 2005. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect. Immun. 73:6952-6961.
22. Kurioka, T., Y. Yunou, and E. Kita. 1998. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect. Immun. 66:1726-1734.
23. Ley, R. E., D. A. Peterson, and J. I. Gordon. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124:837-848.
24. Lindgren, S. W., A. R. Melton, and A. D. O'Brien. 1993. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect. Immun. 61:3832-3842.
25. Lindgren, S. W., J. E. Samuel, C. K. Schmitt, and A. D. O'Brien. 1994. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect. Immun. 62:623-631.
26. Manning, S. D., A. S. Motiwala, A. C. Springman, W. Qi, D. W. Lacher, L. M. Ouellette, J. M. Mladonicky, P. Somsel, J. T. Rudrik, S. E. Dietrich, W. Zhang, B. Swaminathan, D. Alland, and T. S. Whittam. 10 March 2008. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc. Natl. Acad. Sci. USA. [Epub ahead of print] doi:10.1073/pnas.0710834105.
27. Melton-Celsa, A. R., J. E. Rogers, C. K. Schmitt, S. C. Darnell, and A. D. O'Brien. 1998. Virulence of Shiga toxin-producing Escherichia coli (STEC) in orally-infected mice correlates with the type of toxin produced by the infecting strain. Jpn. J. Med. Sci. Biol 51(Suppl):S108- S114.
28. Michino, H., K. Araki, S. Minami, S. Takaya, N. Sakai, M. Miyazaki, A. Ono, and H. Yanagawa. 1999. Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am. J. Epidemiol. 150:787-796.
29. Mundy, R., F. Girard, A. J. FitzGerald, and G. Frankel. 2006. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol. Lett. 265:126-132.
30. Nagano, K., K. Taguchi, T. Hara, S. Yokoyama, K. Kawada, and H. Mori. 2003. Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol. Immunol. 47:125-132.
31. Nagura, T., S. Hachimura, S. Kaminogawa, T. Aritsuka, and K. Itoh. 2005. Characteristic intestinal microflora of specific pathogen-free mice bred in two different colonies and their influence on postnatal murine immunocyte profiles. Exp. Anim. 54:143-148.
32. O'Brien, A. D., V. L. Tesh, A. Donohue-Rolfe, M. P. Jackson, S. Olsnes, K. Sandvig, A. A. Lindberg, and G. T. Keusch. 1992. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180:65-94.
33. Ogura, Y., K. Kurokawa, T. Ooka, K. Tashiro, T. Tobe, M. Ohnishi, K. Nakayama, T. Morimoto, J. Terajima, H. Watanabe, S. Kuhara, and T. Hayashi. 2006. Complexity of the genomic diversity in enterohemorrhagic Escherichia coli O157 revealed by the combinational use of the O157 Sakai OligoDNA microarray and the whole genome PCR scanning. DNA Res. 13:3-14.
34. Ohnishi, M., J. Terajima, K. Kurokawa, K. Nakayama, T. Murata, K. Tamura, Y. Ogura, H. Watanabe, and T. Hayashi. 2002. Genomic diversity of enterohemorrhagic Escherichia coli O157 revealed by whole genome PCR scanning. Proc. Natl. Acad. Sci. USA 99:17043-17048.
35. Paton, A. W., A. J. Bourne, P. A. Manning, and J. C. Paton. 1995. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons. Infect. Immun. 63:2450-2458.
36. Paton, A. W., P. A. Manning, and J. C. Paton. 1995. Increased oral virulence of Escherichia coli expressing a variant Shiga-like toxin type II operon is associated with both A subunit residues Met4 and Gly102. Microb. Pathog. 19:185-191.
37. Quimby, F. W., and R. Luong. 2007. Clinical chemistry of the laboratory mouse, p. 171-216. In J. G. Fox, M. T. Davisson, F. W. Quimby, S. W. Barthold, C. E. Newcomer, and A. L. Smith (ed.), The mouse in biomedical research, 2nd ed., vol. 3. Academic Press, New York, NY.
38. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
39. 2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect. Immun. 71:7129-7139.
40. Robinson, C. M., J. F. Sinclair, M. J. Smith, and A. D. O'Brien. 2006. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc. Natl. Acad. Sci. USA 103:9667-9672.
41. Sharma, S., P. Sachdeva, and J. S. Virdi. 2003. Emerging water-borne pathogens. Appl. Microbiol Biotechnol. 61:424-428.
42. Sheoran, A. S., S. Chapman-Bonofiglio, B. R. Harvey, J. Mukherjee, G. Georgiou, A. Donohue-Rolfe, and S. Tzipori. 2005. Human antibody against Shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect. Immun. 73:4607-4613.
43. Sheoran, A. S., S. Chapman, P. Singh, A. Donohue-Rolfe, and S. Tzipori. 2003. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect. Immun. 71:3125-3130.
44. Shimizu, K., T. Asahara, K. Nomoto, R. Tanaka, T. Hamabata, A. Ozawa, and Y. Takeda. 2003. Development of a lethal Shiga toxin-producing Escherichia coli-infection mouse model using multiple mitomycin C treatment. Microb. Pathog. 35:1-9.
45. Shimizu, K., K. Tanaka, A. Akatsuka, M. Endoh, and Y. Koga. 1999. Induction of glomerular lesions in the kidneys of mice infected with vero toxin-producing Escherichia coli by lipopolysaccharide injection. J. Infect. Dis. 180:1374-1377.
46. Singleton, G. R., and C. J. Krebs. 2007. The secret world of wild mice, p. 25-51. In J. G. Fox, M. T. Davisson, F. W. Quimby, S. W. Barthold, C. E. Newcomer, and A. L. Smith (ed.), The mouse in biomedical research, 2nd ed., vol. 1. Academic Press, New York, NY.
47. Sjogren, R., R. Neill, D. Rachmilewitz, D. Fritz, J. Newland, D. Sharpnack, C. Colleton, J. Fondacaro, P. Gemski, and E. Boedeker. 1994. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 106:306-317.
48. Taguchi, H., M. Takahashi, H. Yamaguchi, T. Osaki, A. Komatsu, Y. Fujioka, and S. Kamiya. 2002. Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. J. Med. Microbiol. 51:336-343.
49. Takahashi, M., H. Taguchi, H. Yamaguchi, T. Osaki, A. Komatsu, and S. Kamiya. 2004. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol. 41:219-226.
50. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086.
51. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
52. Tyler, J. S., M. J. Mills, and D. I. Friedman. 2004. The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression. J. Bacteriol. 186:7670-7679.
53. Wadolkowski, E. A., J. A. Burris, and A. D. O'Brien. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 58:2438-2445.
54. Wadolkowski, E. A., L. M. Sung, J. A. Burris, J. E. Samuel, and A. D. O'Brien. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect. Immun. 58:3959-3965.